Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006

This study has been completed.
Sponsor:
Information provided by:
Amphastar Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT01189396
First received: August 24, 2010
Last updated: January 23, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2011
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)